Middle East and Africa Typhoid Fever Vaccines Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine and Others) and Route of administration (Oral and Injectable), and County

No. of Pages: 87    |    Report Code: TIPRE00016064    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East and Africa Typhoid Fever Vaccines Market

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Middle East and Africa Typhoid Fever Vaccines Market – By Vaccine Type

1.3.2        Middle East and Africa Typhoid Fever Vaccines Market – By Route of Administration

1.3.3        Middle East and Africa Typhoid Fever Vaccines Market – By Country

2.          Middle East and Africa Typhoid Fever Vaccines Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Middle East and Africa Typhoid Fever Vaccines Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Middle East and Africa Typhoid Fever Vaccines Market - Middle East and Africa PEST Analysis

4.3        Expert Opinion

5.          Middle East and Africa Typhoid Fever Vaccines Market Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Growing Initiatives for Typhoid Fever in Middle East and Africa Region

5.2        Key Restraints

5.2.1        Risks Associated with Typhoid Fever Vaccines

5.3        Key Market Opportunities

5.3.1        Growing Pharmaceutical Industry in Middle East

5.4        Future Trend

5.4.1        The Growing Trend of Conjugate Vaccine

5.5        Impact Analysis

6.          Typhoid Fever Vaccines Market – Middle East and Africa Analysis

6.1        Middle East and Africa Typhoid Fever Vaccines Market Revenue Forecasts and Analysis

7.          Typhoid Fever Vaccines Market – By Vaccine Type

7.1        Overview

7.2        Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)

7.3        Live Attenuated Vaccine

7.3.1        Overview

7.3.2        Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.5        Capsular Polysaccharide Vaccines

7.5.1        Overview

7.5.2        Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.6        Conjugate Vaccine

7.6.1        Overview

7.6.2        Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.7        Others

7.7.1        Overview

7.7.2        Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.          Typhoid Fever Vaccines Market Analysis – By Route of Administration

8.1        Overview

8.2        Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)

8.2.1        Oral

8.2.1.1         Overview

8.2.2        Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.3        Injectable

8.3.1        Overview

8.3.2        Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.          Typhoid Fever Vaccines Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1        Middle East and Africa: Typhoid Fever Vaccines Market

9.1.1        Overview

9.1.2        Middle East and Africa: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)

9.1.3        Middle East and Africa: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.1.4        Middle East and Africa: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

9.1.5        Middle East & Africa: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)

9.1.6        Saudi Arabia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1         Saudi Arabia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2         Saudi Arabia: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.1.6.3         Saudi Arabia: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

9.1.7        UAE: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1         UAE: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2         UAE: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.1.7.3         UAE: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

9.1.8        South Africa: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1         South Africa: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2         South Africa: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.1.8.3         South Africa: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

9.1.9        Rest of Middle East & Africa (MEA): Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.1         Rest of MEA: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.2         Rest of MEA: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.1.9.3         Rest of MEA: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

10.       Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market

10.1     Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.       Company Profiles

11.1     Shanghai Institute of Biological Products Co., Ltd.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2     Sanofi

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3     Paxvax Inc.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4     Bharat Biotech

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5     GlaxoSmithKline plc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.       Appendix

12.1     About The Insight Partners

12.2     Glossary of Terms

LIST OF TABLES

Table 1.            Middle East & Africa: Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 2.            Middle East and Africa: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 3.            Saudi Arabia: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 4.            Saudi Arabia: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 5.            UAE: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 6.            UAE: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 7.            South Africa: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 8.            South Africa: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 9.            Rest of MEA: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 10.           Rest of MEA: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 11.           Glossary of Terms, Middle East and Africa Typhoid Fever Vaccines Market

LIST OF FIGURES

Figure 1.          Typhoid Fever Vaccines Market Segmentation

Figure 2.          Middle East and Africa Typhoid Fever Vaccines Market Overview

Figure 3.          Capsular Polysaccharide Vaccines Segment Held Largest Share of Typhoid Fever Vaccines Market

Figure 4.          Saudi Arabia Is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.          Middle East and Africa Typhoid Fever Vaccines Market- Leading Country Markets (US$ Mn)

Figure 6.          Middle East and Africa : PEST Analysis

Figure 7.          Typhoid Fever Vaccines Market Impact Analysis of Drivers and Restraints

Figure 8.          Middle East and Africa Typhoid Fever Vaccines Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.          Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)

Figure 10.        Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)

Figure 15.        Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Middle East and Africa: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 18.        Middle East and Africa: Typhoid Fever Vaccines Market, Revenue and Forecast to 2027 (USD Million)

Figure 19.        Middle East & Africa: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)

Figure 20.        Saudi Arabia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 21.        UAE: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 22.        South Africa: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 23.        Rest of MEA: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in Middle East and Africa Countries

The List of Companies - Middle East and Africa Typhoid Fever Vaccines Market

The List of Companies - Middle East and Africa Typhoid Fever Vaccines Market
  1. GlaxoSmithKline plc
  2. Shanghai institute of biological products co. ltd.
  3. Sanofi
  4. Pax Vax Inc
  5. BHARAT BIOTECH